Lung Cancer Survivors - Know Your Chances Of Recovery

lung cancer survivors Beating the Odds

The researchers analyzed the average percentage of lung cancer survivors is based on two major mjerila.Prvi five years, and the second ten-year survival rate. While early stage cancer patients have a better chance of survival than those in later stages, the data can vary significantly.

National data

Statistics from the National Cancer Institute cancer is divided into small cell and non small stanica.Bivši the worst prognosis. It is usually diagnosed when it has already spread to other organs or lymph nodes, and to grow aggressively. NCI visionary program considers the survival statistics for the second stage of diagnosis. Statistics are further divided according to age, race and gender.

The figures show a low occurrence of lung cancer in all races and both sexes, the chances of developing the disease increase the population ages. SEER data estimates survival rates comparing patients with cancer in the population without cjelini.Pet years, the rate calculated for non-small cell cancer for all races, ages and genders averages 15% -18%. Statistics trends will change this data over time. These changes are called "annual percentage change 'and manifest with a plus or a minus sign or an asterisk if the change was significant.

Objectivity

SEER statistics do not take into account the quality of care between hospitals, despite the importance of this factor for patients. In an independent study commissioned by Cancer Treatment Centers (USA) comparison between the cancer survivors in their facilities and comparable SEER podataka.Rezultati demonstrate the importance of quality of care.

the victims of advanced stage non-small cell LC, CTCAE patient survival rates at six months were 21 percent higher than the national average. In one year they were 16 percent higher, and a year and a half, 11 percent higher. These figures demonstrate the importance of superior care a favorable outcome, but also the value given in each case, for the difference. Approaching the care of patients, with no preconceived notions based on SEER averages may leave more options open to individuals.

In general, long-term survival of small cell carcinomas are low in all populations. NSCLC detected in its early stages offers the patient the best long-term chances for survival.